From: Use of palliative radiotherapy in brain and bone metastases (VARA II study)
H | 3 × 600cGy | 5 × 400 cGy | 10 × 300cGy | Others | Total |
---|---|---|---|---|---|
1 | 3 | 8 | 1 | 12 | |
25% | 66.7% | 8.3% | |||
2 | 13 | 1 | 14 | ||
92.9% | 7.1% | ||||
3 | 58 | 9 | 1 | 68 | |
85.3% | 13.2% | 1.5% | |||
4 | 1 | 2 | 38 | 1 | 42 |
2.4% | 4.7% | 90.5% | 2.4% | ||
5 | 35 | 35 | |||
100% | |||||
6 | 28 | 6 | 34 | ||
82% | 18% | ||||
7 | 24 | 1 | 5 | 30 | |
80% | 3.3% | 16.7% | |||
8 | 22 | 10 | 1 | 33 | |
66.7% | 30.3% | 3% | |||
9 | 10 | 53 | 5 | 1 | 69 |
14.5% | 76.8% | 7.3% | 1.4% | ||
10 | 41 | 1 | 42 | ||
97.6% | 2.4% | ||||
11 | 16 | 63 | 8 | 87 | |
18.4% | 72.4% | 9.2% | |||
12 | 32 | 32 | |||
100% | |||||
T | 93 | 138 | 246 | 21 | 498 |
18.7% | 27.7% | 49.4% | 4.2% |